Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study.
Sunder-Plassmann G, Födinger M, Buchmayer H, Papagiannopoulos M, Wojcik J, Kletzmayr J, Enzenberger B, Janata O, Winkelmayer WC, Paul G, Auinger M, Barnas U, Hörl WH. Sunder-Plassmann G, et al. Among authors: auinger m. J Am Soc Nephrol. 2000 Jun;11(6):1106-1116. doi: 10.1681/ASN.V1161106. J Am Soc Nephrol. 2000. PMID: 10820175 Clinical Trial.
Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.
Kotanko P, Kramar R, Devrnja D, Paschke E, Voigtländer T, Auinger M, Pagliardini S, Spada M, Demmelbauer K, Lorenz M, Hauser AC, Kofler HJ, Lhotta K, Neyer U, Pronai W, Wallner M, Wieser C, Wiesholzer M, Zodl H, Födinger M, Sunder-Plassmann G. Kotanko P, et al. Among authors: auinger m. J Am Soc Nephrol. 2004 May;15(5):1323-9. doi: 10.1097/01.asn.0000124671.61963.1e. J Am Soc Nephrol. 2004. PMID: 15100373
Major determinants of hyperhomocysteinemia in peritoneal dialysis patients.
Vychytil A, Födinger M, Wölfl G, Enzenberger B, Auinger M, Prischl F, Buxbaum M, Wiesholzer M, Mannhalter C, Hörl WH, Sunder-Plassmann G. Vychytil A, et al. Among authors: auinger m. Kidney Int. 1998 Jun;53(6):1775-82. doi: 10.1046/j.1523-1755.1998.00918.x. Kidney Int. 1998. PMID: 9607212 Free article.
Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysis.
Königsbrügge O, Schmaldienst S, Auinger M, Klauser-Braun R, Lorenz M, Tabernig S, Kletzmayr J, Enzenberger B, Eigner M, Hecking M, Siller-Matula JM, Pabinger I, Säemann M, Ay C. Königsbrügge O, et al. Among authors: auinger m. Atherosclerosis. 2020 Apr;298:1-6. doi: 10.1016/j.atherosclerosis.2020.02.011. Epub 2020 Feb 16. Atherosclerosis. 2020. PMID: 32126388
Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIVALDI).
Königsbrügge O, Lorenz M, Auinger M, Schmaldienst S, Klauser-Braun R, Kletzmayr J, Grilz E, Posch F, Antlanger M, Pabinger I, Säemann M, Ay C. Königsbrügge O, et al. Among authors: auinger m. Thromb Res. 2017 Oct;158:59-64. doi: 10.1016/j.thromres.2017.08.011. Epub 2017 Aug 19. Thromb Res. 2017. PMID: 28843824
Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
Kronenberg F, König P, Neyer U, Auinger M, Pribasnig A, Lang U, Reitinger J, Pinter G, Utermann G, Dieplinger H. Kronenberg F, et al. Among authors: auinger m. J Am Soc Nephrol. 1995 Jul;6(1):110-20. doi: 10.1681/ASN.V61110. J Am Soc Nephrol. 1995. PMID: 7579063 Clinical Trial.
Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).
Königsbrügge O, Posch F, Antlanger M, Kovarik J, Klauser-Braun R, Kletzmayr J, Schmaldienst S, Auinger M, Zuntner G, Lorenz M, Grilz E, Stampfel G, Steiner S, Pabinger I, Säemann M, Ay C. Königsbrügge O, et al. Among authors: auinger m. PLoS One. 2017 Jan 4;12(1):e0169400. doi: 10.1371/journal.pone.0169400. eCollection 2017. PLoS One. 2017. PMID: 28052124 Free PMC article.
Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population-based prospective cohort study.
Königsbrügge O, Meisel H, Beyer A, Schmaldienst S, Klauser-Braun R, Lorenz M, Auinger M, Kletzmayr J, Hecking M, Winkelmayer WC, Lang I, Pabinger I, Säemann M, Ay C. Königsbrügge O, et al. Among authors: auinger m. J Thromb Haemost. 2021 Dec;19(12):2984-2996. doi: 10.1111/jth.15508. Epub 2021 Sep 5. J Thromb Haemost. 2021. PMID: 34418291 Free article.
65 results